On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...

The product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining bioequivalence to the reference product.

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

IBSRELA + XPHOZAH fuel growth, patent runway to 2041, and pipeline upside. Read the full analysis here of ARDX stock.

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Depression is one of the most widespread mental health disorders worldwide, affecting approximately 4% of the global ...

AI is forcing private equity and venture capital firms to rethink traditional investment metrics. How investors are adapting ...

The US and Taiwan have signed a trade agreement that will slash tariffs on the country to 15 per cent in exchange for a ...

DFW, Great Point Partners, SK Capital and Water Street Healthcare Partners are among the PE firms investing in pharma ...

Scientists have uncovered a troubling role for a vitamin A byproduct in cancer, which appears to help tumours slip past the ...

ARG, a leading technology advisory firm, today announced that 95% of its employees have achieved AI Foundational certification, marking a significant milestone in the company's seven-year AI ...

When Jorie Kraus was diagnosed with an incurable rare disease, two young researchers created an AI tool to find a treatment.